We are in the business of excellent clinical evidence. EMA wants to partner with stakeholders, including those from industry, to drive up the quality of evidence…
Our dedication to advancing technology and making tangible differences in healthcare is unwavering. Partnering with Jacobio Pharmaceuticals offers a unique opportunity to collaborate on groundbreaking initiatives…
The reluctance to invest in phase one trials is multifaceted. One aspect is the fear of generic molecule development in India, even though the regulatory environment…
We are steadfast in our mission to ensure the availability of pharmaceutical products and supplies, particularly in the face of widespread shortages and surpluses
An alarming statistic is that half of the individuals with diabetes remain undiagnosed. Moreover, Indians tend to develop diabetes a decade earlier than their Western counterparts,…
India is a market with great potential. However, it's important to recognize that the market is price-sensitive, requiring patience and a strategic approach